Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study. [electronic resource]
Producer: 20090421Description: 658-65 p. digitalISSN:- 1097-6744
- Aged
- Atherosclerosis -- drug therapy
- Cause of Death -- trends
- Clopidogrel
- Double-Blind Method
- Ethnicity
- Female
- Follow-Up Studies
- Hemorrhage -- ethnology
- Humans
- Incidence
- Male
- Middle Aged
- Myocardial Ischemia -- ethnology
- Platelet Aggregation Inhibitors -- adverse effects
- Prognosis
- Prospective Studies
- Risk Factors
- Stroke -- ethnology
- Ticlopidine -- adverse effects
- Time Factors
- United States
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.